Core Laboratories Inc. CLB

10.39 (0.10) (0.95%) as of 25 Sep
Market cap
$481.3M
P/E
20.0×
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Cash and Short Term Investments
14.76 14.40 13.12 11.09 13.81 17.70 15.43 15.12 19.16 22.70
Receivables
120.76 140.61 143.15 138.11 92.87 106.74 115.10 123.07 122.08 120.80
Inventory
33.72 33.32 45.66 50.16 38.15 45.44 60.45 71.70 59.40 54.50
Other current assets
6.51 6.51 13.70 5.93 6.23 5.11 5.06 5.09 10.52 6.94
Total current assets
186.46 207.43 230.98 221.24 165.85 189.06 211.70 223.14 221.33 214.67
Property, Plant, Equpment (Net)
129.88 123.10 122.92 123.51 115.29 110.95 105.03 99.63 97.06 99.45
Goodwill and Intangible Assets (Total)
188.98 188.44 232.47 230.88 108.03 107.58 106.93 106.37 105.85 112.91
Long Term Assets (Tax, Deferred)
20.61 10.72 11.25 67.31 72.78 70.46 68.57 69.20 69.61 67.38
Long-term assets (Other)
47.12 55.13 51.22 56.05 40.25 41.41 33.75 34.22 34.79 35.26
Total non-current assets
386.59 377.39 417.85 553.44 402.73 391.80 366.65 363.26 363.80 369.35
Total Assets
573.05 584.81 648.83 774.67 568.58 580.85 578.35 586.40 585.13 584.01
Accounts Payable
33.72 41.70 41.16 35.61 23.03 29.73 45.85 33.51 34.55 37.28
Accrued Expenses
19.41 28.89 22.55 26.69 26.53 20.83 23.43 18.79 22.90 26.53
Current Part of Taxes to Pay
15.72 0.83 2.92 6.32 8.35 6.50 3.03 7.28 9.71 4.26
Current Revenue (Deferred)
15.69 12.63 17.33 13.38 5.46 7.77 5.94 4.76 9.33 5.55
Other current liabilities
13.67 9.23 11.11 9.38 8.40 7.68 8.36 7.65 8.16 16.68
Total current liabilities
104.02 100.58 102.55 111.59 89.75 90.78 103.14 88.10 102.45 106.02
Long Term Debt (Total)
216.49 226.99 289.77 305.28 259.43 188.64 172.39 163.13 126.11 110.26
Long Term Tax Liability (Deferred)
6.28 5.32 7.63 27.34 20.59 24.34 22.88 12.70 9.07 8.00
Non-current Liabilities (Other)
90.97 103.19 87.98 83.66 67.13 66.81 52.70 50.58 51.85 45.23
Total non-current liabilities
313.73 335.50 385.38 480.94 403.26 329.07 286.27 268.49 230.37 205.79
Total liabilities
417.76 436.08 487.93 592.53 493.01 419.85 389.40 356.59 332.81 311.80
Additional Paid In Capital
52.85 54.46 57.44 51.87 41.18 101.12 102.25 110.01 109.55 110.25
Common Stock (Net)
1.15 1.15 1.15 1.15 1.15 1.19 1.19 0.47 0.47 0.47
Retained Earnings
187.96 173.86 156.13 160.54 50.46 68.35 85.95 120.76 144.86 172.66
Treasury Stock
80.77 76.27 52.50 29.36 14.08 4.08 1.36 1.45 2.54 11.59
Common Equity (Total)
155.30 148.73 160.90 182.14 75.57 161.00 188.95 229.81 252.32 272.21
Shareholders Equity (Total)
155.30 148.73 160.90 182.14 75.57 161.00 188.95 229.81 252.32 272.21
Shareholders Equity and Liabilities (Total)
573.05 584.81 648.83 774.67 568.58 580.85 578.35 586.40 585.13 584.01
Shares (Common)
44.15 44.18 44.32 44.47 44.57 46.35 46.63 46.86 46.83 46.10
Shareholders Equity (Tangible)
(33.68) (39.71) (71.57) (48.74) (32.45) 53.42 82.03 123.44 146.47 159.30
Net Debt
201.72 212.59 276.65 294.19 245.63 170.93 156.96 148.01 106.95 87.55
Total Debt
216.49 226.99 289.77 305.28 259.43 188.64 172.39 163.13 126.11 110.26

Fold the line items

In millions of $ except per-share values · columns are period end dates